456 related articles for article (PubMed ID: 35008370)
1. Natural and Synthetic Estrogens in Chronic Inflammation and Breast Cancer.
Maharjan CK; Mo J; Wang L; Kim MC; Wang S; Borcherding N; Vikas P; Zhang W
Cancers (Basel); 2021 Dec; 14(1):. PubMed ID: 35008370
[TBL] [Abstract][Full Text] [Related]
2. Disruption of 3D MCF-12A breast cell cultures by estrogens--an in vitro model for ER-mediated changes indicative of hormonal carcinogenesis.
Marchese S; Silva E
PLoS One; 2012; 7(10):e45767. PubMed ID: 23056216
[TBL] [Abstract][Full Text] [Related]
3. Estrogen-mediated inactivation of FOXO3a by the G protein-coupled estrogen receptor GPER.
Zekas E; Prossnitz ER
BMC Cancer; 2015 Oct; 15():702. PubMed ID: 26470790
[TBL] [Abstract][Full Text] [Related]
4. miRNA-34b as a tumor suppressor in estrogen-dependent growth of breast cancer cells.
Lee YM; Lee JY; Ho CC; Hong QS; Yu SL; Tzeng CR; Yang PC; Chen HW
Breast Cancer Res; 2011; 13(6):R116. PubMed ID: 22113133
[TBL] [Abstract][Full Text] [Related]
5. Insight into the mechanism of tetrachlorobisphenol A (TCBPA)-induced proliferation of breast cancer cells by GPER-mediated signaling pathways.
Lei B; Tang Q; Sun S; Zhang X; Huang Y; Xu L
Environ Pollut; 2021 Apr; 275():116636. PubMed ID: 33582643
[TBL] [Abstract][Full Text] [Related]
6. A role for G-protein coupled estrogen receptor (GPER) in estrogen-induced carcinogenesis: Dysregulated glandular homeostasis, survival and metastasis.
Filardo EJ
J Steroid Biochem Mol Biol; 2018 Feb; 176():38-48. PubMed ID: 28595943
[TBL] [Abstract][Full Text] [Related]
7. AHR and GPER mediate the stimulatory effects induced by 3-methylcholanthrene in breast cancer cells and cancer-associated fibroblasts (CAFs).
Cirillo F; Lappano R; Bruno L; Rizzuti B; Grande F; Guzzi R; Briguori S; Miglietta AM; Nakajima M; Di Martino MT; Maggiolini M
J Exp Clin Cancer Res; 2019 Aug; 38(1):335. PubMed ID: 31370872
[TBL] [Abstract][Full Text] [Related]
8. Role of ER-α36 in breast cancer by typical xenoestrogens.
Liu J; Xu Z; Ma X; Huang B; Pan X
Tumour Biol; 2015 Sep; 36(10):7355-64. PubMed ID: 26337277
[TBL] [Abstract][Full Text] [Related]
9. Exogenous hormonal regulation in breast cancer cells by phytoestrogens and endocrine disruptors.
Albini A; Rosano C; Angelini G; Amaro A; Esposito AI; Maramotti S; Noonan DM; Pfeffer U
Curr Med Chem; 2014; 21(9):1129-45. PubMed ID: 24304271
[TBL] [Abstract][Full Text] [Related]
10. The G Protein-Coupled Estrogen Receptor (GPER) Expression Correlates with Pro-Metastatic Pathways in ER-Negative Breast Cancer: A Bioinformatics Analysis.
Talia M; De Francesco EM; Rigiracciolo DC; Muoio MG; Muglia L; Belfiore A; Maggiolini M; Sims AH; Lappano R
Cells; 2020 Mar; 9(3):. PubMed ID: 32143514
[TBL] [Abstract][Full Text] [Related]
11. MIBE acts as antagonist ligand of both estrogen receptor α and GPER in breast cancer cells.
Lappano R; Santolla MF; Pupo M; Sinicropi MS; Caruso A; Rosano C; Maggiolini M
Breast Cancer Res; 2012 Jan; 14(1):R12. PubMed ID: 22251451
[TBL] [Abstract][Full Text] [Related]
12. Combinations of physiologic estrogens with xenoestrogens alter calcium and kinase responses, prolactin release, and membrane estrogen receptor trafficking in rat pituitary cells.
Jeng YJ; Kochukov M; Watson CS
Environ Health; 2010 Oct; 9():61. PubMed ID: 20950447
[TBL] [Abstract][Full Text] [Related]
13. Estrogenic activity of natural and synthetic estrogens in human breast cancer cells in culture.
Zava DT; Blen M; Duwe G
Environ Health Perspect; 1997 Apr; 105 Suppl 3(Suppl 3):637-45. PubMed ID: 9168008
[TBL] [Abstract][Full Text] [Related]
14. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
Menendez JA; Oza BP; Colomer R; Lupu R
Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
[TBL] [Abstract][Full Text] [Related]
15. SIRT1 and Estrogen Signaling Cooperation for Breast Cancer Onset and Progression.
Liarte S; Alonso-Romero JL; Nicolás FJ
Front Endocrinol (Lausanne); 2018; 9():552. PubMed ID: 30319540
[TBL] [Abstract][Full Text] [Related]
16. Estrogen Receptors Mediated Negative Effects of Estrogens and Xenoestrogens in Teleost Fishes-Review.
Wojnarowski K; Cholewińska P; Palić D; Bednarska M; Jarosz M; Wiśniewska I
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269746
[TBL] [Abstract][Full Text] [Related]
17. Possible role of phytoestrogens in breast cancer via GPER-1/GPR30 signaling.
Molina L; Bustamante FA; Bhoola KD; Figueroa CD; Ehrenfeld P
Clin Sci (Lond); 2018 Dec; 132(24):2583-2598. PubMed ID: 30545896
[TBL] [Abstract][Full Text] [Related]
18. Estrogen-induced reactive oxygen species-mediated signalings contribute to breast cancer.
Okoh V; Deoraj A; Roy D
Biochim Biophys Acta; 2011 Jan; 1815(1):115-33. PubMed ID: 21036202
[TBL] [Abstract][Full Text] [Related]
19. Activating Mutations of ESR1, BRCA1 and CYP19 Aromatase Genes Confer Tumor Response in Breast Cancers Treated with Antiestrogens.
Suba Z
Recent Pat Anticancer Drug Discov; 2017; 12(2):136-147. PubMed ID: 28245776
[TBL] [Abstract][Full Text] [Related]
20. GPER mediates enhanced cell viability and motility via non-genomic signaling induced by 17β-estradiol in triple-negative breast cancer cells.
Yu T; Liu M; Luo H; Wu C; Tang X; Tang S; Hu P; Yan Y; Wang Z; Tu G
J Steroid Biochem Mol Biol; 2014 Sep; 143():392-403. PubMed ID: 24874276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
